GlassScriptPhysician profile
Maci J Mcdermott
NPI 1093158818
$1,750.06
in general payments reported to CMS, 2019-2025
25 companies · $292 in 2025
The $292 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $88.78 · 2021: $336 · 2022: $313 · 2023: $285 · 2024: $156 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $236.89 | 2019-2024 | |
| Corium, LLC | $196.60 | 2021-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $187.89 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $154.97 | 2020-2024 | Bexsero |
| Sanofi Pasteur INC. | $111.09 | 2023-2025 | |
| Sobi, INC | $98.29 | 2019-2023 | |
| Neos Therapeutics, LP | $96.03 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $96.02 | 2019-2022 | |
| Tris Pharma INC | $92.06 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $74.24 | 2019-2025 | Gardasil 9, Enflonsia, Vaxelis |
| Seqirus USA INC | $59.79 | 2021-2025 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $40.15 | 2023-2024 | Flumist Quadrivalent |
| Mdd US Operations, LLC | $36.84 | 2025 | Qelbree |
| Abbvie INC. | $32.08 | 2021-2022 | |
| Shire North American Group INC | $27.82 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $27.55 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $25.30 | 2021 | |
| Verrica Pharmaceuticals INC. | $24.78 | 2023 | Ycanth |
| Mirum Pharmaceuticals, INC. | $22.32 | 2025 | Cholbam |
| Nestle Healthcare Nutrition INC. | $19.50 | 2023 | |
| Ironshore Pharmaceuticals INC. | $19.11 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.99 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $17.88 | 2025 | Neffy |
| Pbg Puerto Rico LLC | $17.69 | 2021 | |
| Sarepta Therapeutics, INC. | $17.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maci Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.